Sputum eosinophilia in idiopathic pulmonary fibrosis.

Sputum eosinophilia in idiopathic pulmonary fibrosis.

OBJECTIVES AND DESIGN: Cough is a common symptom in idiopathic pulmonary fibrosis that is difficult to treat and has a major impact on quality of life. We tested the hypothesis that the cough and increased cough reflex sensitivity seen in patients with idiopathic pulmonary fibrosis may be due to air...

Bibliografski detalji
Glavni autori:	Birring, S, Parker, D, McKenna, S, Hargadon, B, Brightling, C, Pavord, I, Bradding, P
Format:	Journal article
Jezik:	English
Izdano:	2005

Slični predmeti

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
od: Brightling, C, i dr.
Izdano: (2005)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
od: Green, R, i dr.
Izdano: (2002)

Induced sputum inflammatory mediator concentrations in chronic cough.
od: Birring, S, i dr.
Izdano: (2004)

Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study.
od: Birring, S, i dr.
Izdano: (2002)

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
od: Brightling, C, i dr.
Izdano: (2000)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
od: Bafadhel, M, i dr.
Izdano: (2009)

Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.
od: Saha, S, i dr.
Izdano: (2008)

Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma.
od: Desai, D, i dr.
Izdano: (2013)

Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.
od: Bafadhel, M, i dr.
Izdano: (2012)

The influence of age on induced sputum differential cell counts in normal subjects.
od: Thomas, R, i dr.
Izdano: (2004)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
od: Brightling, C, i dr.
Izdano: (2000)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
od: Brightling, C, i dr.
Izdano: (2000)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
od: Berry, M, i dr.
Izdano: (2004)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
od: Saha, S, i dr.
Izdano: (2008)

Airway function and markers of airway inflammation in patients with treated hypothyroidism.
od: Birring, S, i dr.
Izdano: (2005)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
od: Green, R, i dr.
Izdano: (2002)

Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability.
od: Brightling, C, i dr.
Izdano: (2001)

Blood and sputum eosinophilia in COPD exacerbation
od: Laila Ashour Helala, i dr.
Izdano: (2022-09-01)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
od: Brightling, C, i dr.
Izdano: (2002)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
od: Brightling, C, i dr.
Izdano: (2003)

Significance of assessment of sputum eosinophilia in bronchial asthma
od: Reshma.M1 , Sharadrutha.A2 , C.N.Prasad3
Izdano: (2018-04-01)

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
od: Brightling, C, i dr.
Izdano: (2014)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
od: Green, R, i dr.
Izdano: (2006)

Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis.
od: Birring, S, i dr.
Izdano: (2003)

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
od: Agbetile, J, i dr.
Izdano: (2012)

Are sputum autoantibodies more clinically relevant in idiopathic pulmonary fibrosis than serum autoantibodies?
od: Kuimiao Deng, i dr.
Izdano: (2022-01-01)

Observational study of the natural history of eosinophilic bronchitis.
od: Berry, M, i dr.
Izdano: (2005)

Idiopathic chronic cough and organ-specific autoimmune diseases: a case-control study.
od: Birring, S, i dr.
Izdano: (2004)

Idiopathic chronic cough and organ-specific autoimmune disease.
od: Birring, S, i dr.
Izdano: (2006)

Underestimation of airway luminal eosinophilia by quantitative sputum cytometry
od: Melanie Kjarsgaard, i dr.
Izdano: (2021-07-01)

Evidence of a role of tumor necrosis factor alpha in refractory asthma.
od: Berry, M, i dr.
Izdano: (2006)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
od: Shaw, D, i dr.
Izdano: (2007)

A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer
od: M. Monsur Ali, i dr.
Izdano: (2022-12-01)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
od: Siva, R, i dr.
Izdano: (2007)

Idiopathic pulmonary fibrosis
od: Noble Paul W, i dr.
Izdano: (2008-03-01)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
od: Siddiqui, S, i dr.
Izdano: (2007)

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions
od: Giovanni Ferrara, i dr.
Izdano: (2018-02-01)

New insights into the role of the mast cell in asthma.
od: Brightling, C, i dr.
Izdano: (2003)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
od: Wardlaw, A, i dr.
Izdano: (2004)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
od: Connolly, CM, i dr.
Izdano: (2017)